iRobot to be acquired by Picea Robotics after filing for bankruptcy

iRobot filed a pre-packaged Chapter 11 in Delaware and will be acquired in a court-supervised process by its secured lender and primary contract manufacturer, Shenzhen Picea Robotics, which is set to take 100% of equity, cancel existing shares, delist the company and leave current public shareholders with no recovery; the transaction is expected to close by February 2026. Management said the filing is designed to shore up the balance sheet, reduce debt and allow continued product development and day-to-day operations (including product support, app functionality and supply-chain activities) under Picea’s ownership after years of competitive pressure, supply-chain challenges and a failed Amazon deal. Shares plunged about 73% to roughly $1.15 on the news.

Analysis

iRobot filed a pre-packaged Chapter 11 in the District of Delaware and will be acquired by its secured lender and primary contract manufacturer, Shenzhen Picea Robotics, through a court-supervised process with closing expected by February 2026. Under the proposed plan Picea would take 100% of equity, existing shares would be cancelled and current public stockholders are not expected to receive any recovery; the company will be delisted from Nasdaq.

Management states the filing is intended to reduce debt and preserve operations, and iRobot has filed motions to meet employee and vendor obligations; the company also committed that day-to-day product support, app functionality and supply-chain activities will continue during restructuring. The filing cites multi-year competitive pressures, supply-chain challenges and a failed Amazon acquisition as drivers of the restructuring.

Market reaction was severe: shares fell about 73% to roughly $1.15 and sentiment outputs label this development strongly negative for equity holders. Key near-term items to monitor are court approval of the plan, any creditor recoveries or challenges, and Picea’s post-close execution of R&D and cost discipline that will determine longer-term viability as a private company.

Key Decisions for Investors

• Public equity holders should treat IRBT shares as effectively worthless pending court confirmation and consider exiting positions given the stated cancellation of existing shares
• Creditors, vendors and potential claimants should closely monitor the Chapter 11 docket, DIP financing motions and the February 2026 timeline to assess potential recovery or negotiation leverage
• Vendors, suppliers and counterparties should verify ongoing operational commitments through court filings and contract terms since day-to-day operations are stated to continue but execution risk remains
• Private-market or strategic investors may monitor post-close performance under Picea for turnaround signals, but delay redeployment until there is clear evidence of margin stabilization and execution against R&D and manufacturing integration plans